OPDP Facebook Regulatory Alert

The Food and Drug Administration's Office of Prescription Drug Promotion released an untitled letter for inappropriate use of Facebook to promote a prescription drug. Digitas Health just released a Regulatory Alert to help other companies marketing prescription products learn from this action and ensure they don't face the same consequences. Here's the alert: http://www.scribd.com/doc/212262834/DH-Regulatory-Alert-OPDP-Issues-First-Letter-for-Facebook-Page-Activity

No comments:

Post a Comment